[Expression and Clinical Significance of MAGE-4 Gene in Human Hepatocellular Carcinoma].

Haitao Zhao,Jing'an Rui,Xu Cong,Yi Zhao,Shaobin Wang,Shuguang Chen,Yu Wang,Xisheng Leng,Weifeng Chen

DOI: https://doi.org/10.3760/j.issn:1007-3418.2002.02.005

2002-01-01

Abstract:OBJECTIVE To explore the possibility of MAGE-4 gene encoding protein used as a target for immunotherapy in HCC patients. METHODS The expression of MAGE-4 gene in tumor tissues and tumor adjacent non-HCC liver tissues was examined by the RT-PCR method. The relationship between positive expression rate of MAGE-4 gene and other clinical and lab data including AFP, AFU, anti-HCV, HBsAg, AFP mRNA, and the diameter of the tumors in HCC patients was also determined. RESULTS The positive expression rate of MAGE-4 gene was significantly higher in the tumor than in tumor surrounding tissues (38.7% vs 0%, P<0.01), while the positive expression rate of MAGE-4 gene had no relationship with the clinical and lab data (P>0.05). CONCLUSIONS The high frequency of MAGE-4 gene expression in HCC suggests the possibility of MAGE-4 gene encoding protein as a target for immunotherapy in HCC patients, but the expression has no relationship with the tumor metastasis and the recurrence of HCC.